The PNPLA3 rs738409 GG variant is associated with an increased risk for MASLD progression and advanced fibrosis (Valenti et al., 2010; Krawczyk et al., 2020; Singal et al., 2014; Shen et al., 2015). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.